Pharmacological Management
First-Generation Antipsychotics (FGAs)
- First-generation antipsychotics (typical antipsychotics) primarily block dopamine D2 receptors and are effective for treating positive symptoms. Examples include haloperidol, chlorpromazine, fluphenazine, and perphenazine.
- FGAs have a higher risk of extrapyramidal symptoms (EPS) including acute dystonia, akathisia, parkinsonism, and tardive dyskinesia. They may also cause anticholinergic effects, orthostatic hypotension, and neuroleptic malignant syndrome.
Key Points
- Primarily block dopamine D2 receptors
- More effective for positive than negative symptoms
- Higher risk of extrapyramidal side effects
Second-Generation Antipsychotics (SGAs)
- Second-generation antipsychotics (atypical antipsychotics) block both dopamine D2 and serotonin 5-HT2A receptors. Examples include risperidone, olanzapine, quetiapine, ziprasidone, aripiprazole, and clozapine.
- SGAs generally have a lower risk of EPS but higher risk of metabolic side effects including weight gain, hyperglycemia, and dyslipidemia. Clozapine, while particularly effective for treatment-resistant schizophrenia, requires regular monitoring for agranulocytosis.
Key Points
- Block both dopamine D2 and serotonin 5-HT2A receptors
- May be more effective for negative and cognitive symptoms
- Lower risk of EPS but higher risk of metabolic side effects
- Clozapine is most effective for treatment-resistant cases but requires monitoring for agranulocytosis
Comparison of First and Second Generation Antipsychotics
| Feature |
First-Generation (Typical) |
Second-Generation (Atypical) |
| Receptor action |
Primarily D2 antagonism |
D2 and 5-HT2A antagonism |
| Efficacy for positive symptoms |
Effective |
Effective |
| Efficacy for negative symptoms |
Limited |
Moderately effective |
| Extrapyramidal symptoms |
High risk |
Lower risk |
| Metabolic effects |
Lower risk |
Higher risk |
| Examples |
Haloperidol, Chlorpromazine |
Risperidone, Olanzapine, Clozapine |
Important Alert: Monitor patients on clozapine for signs of agranulocytosis (fever, sore throat, fatigue, infection). Regular WBC monitoring is mandatory: weekly for 6 months, biweekly for 6 months, then monthly thereafter if counts remain stable.
Nursing Assessment and Interventions
Assessment
- Conduct a comprehensive mental status examination assessing appearance, behavior, speech, mood, affect, thought process, thought content (including delusions, hallucinations), insight, and judgment. Use structured assessment tools when appropriate.
- Assess for safety concerns including suicidal ideation, homicidal ideation, and ability to care for self. Patients with schizophrenia have a 5-10% lifetime risk of suicide, with highest risk during periods of insight, depression, or after discharge.
- Evaluate medication adherence, side effects, and response to treatment. Non-adherence is common (approximately 50%) and is a major cause of relapse and rehospitalization.
Key Points
- Assess for positive, negative, and cognitive symptoms
- Evaluate safety risks including suicide (5-10% lifetime risk)
- Monitor medication adherence and side effects
Nursing Interventions
- Establish therapeutic relationship using clear, concise communication. Avoid challenging delusions directly; instead, focus on the patient's feelings and reality-based topics.
- Provide structure and routine to decrease anxiety and help patients organize their thoughts and activities.
- Implement safety measures for patients at risk of harm to self or others, including close observation, removal of dangerous objects, and appropriate level of supervision.
- Administer medications as prescribed and monitor for therapeutic effects and side effects. Provide patient education about the importance of medication adherence.
- Teach coping strategies for hallucinations, such as reality testing, distraction techniques, and seeking support when symptoms intensify.
- Promote self-care activities and assist with activities of daily living as needed. Use a step-by-step approach for complex tasks.
- Facilitate family education and involvement in care. Family psychoeducation has been shown to reduce relapse rates by approximately 50%.
Key Points
- Use clear, concise communication and avoid challenging delusions directly
- Provide structure and routine to decrease anxiety
- Monitor medication adherence and educate about importance of continued treatment
- Involve family in treatment when possible
Clinical Scenario: Managing Hallucinations
A 23-year-old male patient with schizophrenia appears frightened and is seen responding to internal stimuli, looking at empty spaces in the room, and covering his ears. He states, "They're telling me to hurt myself."
Appropriate Nursing Response:
- Ensure patient safety first; assess suicide risk and implement precautions as needed
- Approach calmly and acknowledge the patient's distress: "I can see you're hearing voices that are upsetting you. I don't hear them, but I understand they seem real to you."
- Use reality-based interventions: "Let's focus on what's happening here. You're in the hospital and you're safe."
- Offer coping strategies: "Would listening to music with headphones help block out the voices?"
- Administer PRN medications if ordered and appropriate
- Document the episode, interventions, and patient response
Study Tips and Memory Aids
Antipsychotic Medications
Memory Aid: Side Effects of Antipsychotics
TEAM approach to remember antipsychotic side effects:
- T - Tardive dyskinesia (involuntary movements, especially of face/tongue)
- E - Extrapyramidal symptoms (acute dystonia, parkinsonism, akathisia)
- A - Anticholinergic effects (dry mouth, blurred vision, constipation, urinary retention)
- M - Metabolic syndrome (weight gain, hyperglycemia, dyslipidemia)
Memory Aid: First vs. Second Generation Antipsychotics
First Generation = "Typical" = "T" for Tremors (higher risk of EPS)
Second Generation = "Atypical" = "A" for Appetite/weight gain (higher risk of metabolic effects)
Memory Aid: EPS Symptoms
ADAPT to remember extrapyramidal symptoms:
- Akathisia (motor restlessness)
- Dystonia (muscle spasms)
- Akinesia (reduced movement)
- Parkinsonism (tremor, rigidity)
- Tardive dyskinesia (late-onset involuntary movements)
Communication Strategies
Memory Aid: CLEAR Communication with Schizophrenia Patients
- Concise: Use short, simple sentences
- Literal: Avoid metaphors, idioms, and abstract language
- Explicit: Be specific about expectations and instructions
- Affirming: Validate the patient's feelings while redirecting from delusions
- Reality-based: Focus on here-and-now topics
Quick Check: Test Your Knowledge
1. Which of the following is a negative symptom of schizophrenia?
a) Hallucinations
b) Delusions
c) Avolition
d) Disorganized speech
Answer: c) Avolition
2. Which medication requires regular WBC monitoring due to risk of agranulocytosis?
a) Risperidone
b) Haloperidol
c) Clozapine
d) Olanzapine
Answer: c) Clozapine
3. A patient with schizophrenia is experiencing akathisia. This is characterized by:
a) Involuntary tongue movements
b) Muscle rigidity and tremor
c) Restlessness and inability to sit still
d) Sustained muscle contractions
Answer: c) Restlessness and inability to sit still
Common Pitfalls
Common Pitfall: Focusing only on positive symptoms while neglecting negative symptoms. Negative symptoms often have greater impact on long-term functioning and quality of life but are frequently overlooked in assessment and treatment planning.
Common Pitfall: Challenging delusions directly. This can damage therapeutic relationship and increase patient distress. Instead, acknowledge the patient's beliefs while focusing on feelings and reality-based topics.
Common Pitfall: Discontinuing antipsychotic medication too soon after symptom improvement. Maintenance therapy is essential for preventing relapse. Patients should continue treatment for at least 1-2 years after first episode and often longer for multiple episodes.
Common Pitfall: Overlooking physical health monitoring. Patients with schizophrenia have 2-3 times higher mortality rate than general population, largely due to physical health conditions. Regular monitoring of metabolic parameters, cardiovascular health, and lifestyle factors is essential.
Self-Assessment Checklist